- 1 Summary
- 2 Effects
- 3 Legal status
- 4 FAQ
- 4.1 1. What is 3-Fluoromethcathinone (3-FMC)?
- 4.2 2. Has 3-FMC been scientifically studied for its effects and safety?
- 4.3 3. What is the legal status of 3-FMC in different countries?
- 4.4 4. What is the relationship between 3-FMC and 3-Fluoroisomethcathinone?
- 4.5 5. Is 3-FMC used for any medical purposes?
- 5 References
3-Fluoromethcathinone, commonly called 3-FMC, is a chemical compound in the phenethylamine, amphetamine, and cathinone classes. It has been made available for purchase on online platforms as a designer drug. Notably, it shares a structural isomer relationship with flephedrone (4-fluoromethcathinone).
During the synthesis of 3-FMC, a by-product called 3-Fluoroisomethcathinone is produced. However, the specific activity and effects of this compound remain unknown.
|Chemical and physical data|
|Molar mass||181.210 g·mol−1|
Scientific research has not yet explored the effects and safety profile of this chemical.
- 3-FMC is classified as a Schedule I controlled substance in the United States.
- Within the United Kingdom, 3-FMC falls under controlled drugs, subject to the cathinone blanket ban.
- In Germany, 3-FMC is categorized as an Anlage II controlled drug.
- The Czech Republic has prohibited the use of 3-FMC.
1. What is 3-Fluoromethcathinone (3-FMC)?
- 3-FMC is a synthetic compound in the phenethylamine, amphetamine, and cathinone. It is known for being marketed and sold online as a designer drug.
2. Has 3-FMC been scientifically studied for its effects and safety?
- As of the current information available, scientific research on the effects and safety of 3-FMC has yet to be conducted. Therefore, its potential risks and benefits remain unknown.
3. What is the legal status of 3-FMC in different countries?
- The legal status of 3-FMC varies from country to country. As of the most recent information available:
- It is classified as a Schedule I controlled substance in the United States.
- In the United Kingdom, 3-FMC is a controlled drug under the cathinone blanket ban.
- In Germany, it is categorized as an Anlage II controlled drug.
- The Czech Republic has banned the use of 3-FMC.
- It’s essential to check local laws and regulations for the most up-to-date information regarding the legal status of 3-FMC in your area.
4. What is the relationship between 3-FMC and 3-Fluoroisomethcathinone?
- During the synthesis of 3-FMC, a by-product called 3-Fluoroisomethcathinone is produced. However, this by-product’s specific activity and effects are unknown and have not been studied.
5. Is 3-FMC used for any medical purposes?
- As of my last knowledge update in September 2021, 3-FMC had no recognized medical applications and was primarily encountered as a recreational or designer drug.
Please note that the legal and scientific landscape surrounding 3-FMC may have evolved since my last update in September 2021. Stay informed about this compound’s latest developments and regulations if you have any concerns or interests in its use or research.
- In October 2015, Ondra P, Válka I, Knob R, Ginterová P, and Maier V conducted an analysis titled “Analysis of Amphetamine-Derived Designer Drugs by Gas Chromatography with Mass Spectrometry.” This research was published in the Journal of Analytical Toxicology (Volume 40, Issue 1) and can be referenced with the DOI: 10.1093/jat/bkv113. The PMID is 26446487.
- In March 2009, Archer RP authored a study on “Fluoromethcathinone, a new substance of abuse.” This research was published in Forensic Science International (Volume 185, Issues 1–3) and can be accessed with the DOI: 10.1016/j.forsciint.2008.11.013. The PMID is 19195800.
- Susannah Davies and colleagues reported two cases of confirmed ingestion of novel designer compounds, specifically 4-methylmethcathinone (Mephedrone) and 3-fluoromethcathinone.
- The “Schedules of Controlled Substances” included the temporary placement of 10 synthetic cathinones into Schedule I.
- “Látky, o které byl doplněn seznam č. 4 psychotropních látek (příloha č. 4 k nařízení vlády č. 463/2013 Sb.)” is a document in Czech issued by the Ministerstvo zdravotnictví (Ministry of Health). It pertains to substances added to the list of psychotropic substances as an appendix to government regulation number 463/2013 Sb. This document is available in PDF format.